Enhanced Kat3A/Catenin transcription: a common mechanism of therapeutic resistance

Abstract

Cancers are heterogeneous at the cellular level. Cancer stem cells/tumor initiating cells (CSC/TIC) both initiate tumorigenesis and are responsible for therapeutic resistance and disease relapse. Elimination of CSC/TIC should therefore be able to reverse therapy resistance. In principle, this could be accomplished by either targeting cancer stem cell surface markers or “stemness” pathways. Although the successful therapeutic elimination of “cancer stemness” is a critical goal, it is complex in that it should be achieved without depletion of or increases in somatic mutations in normal tissue stem cell populations. In this perspective, we will discuss the prospects for this goal via pharmacologically targeting differential Kat3 coactivator/Catenin usage, a fundamental transcriptional control mechanism in stem cell biology.

Keywords

Kat3 coactivator / CREB-binding protein / p300 / therapy resistance / stem cell / cancer stem cell

References

[1] Fitzmaurice C,Al Lami FH.Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study..JAMA Oncol2018;4:1553-68 PMCID:PMC6248091

[2] Sabnis AJ.Principles of resistance to targeted cancer therapy: lessons from basic and translational cancer biology..Trends Mol Med2019;25:185-97 PMCID:PMC6401263

[3] Reya T,Clarke MF.Stem cells, cancer, and cancer stem cells..Nature2001;414:105-11

[4] Yadav AK.Cancer stem cells: acquisition, characteristics, therapeutic implications, targeting strategies and future prospects..Stem Cell Rev2019;15:331-55

[5] Agnoletto C,Minotti L,Crudele F.Heterogeneity in circulating tumor cells: the relevance of the stem-cell subset..Cancers (Basel)2019;11: PMCID:PMC6521045

[6] Afify SM.Conversion of stem cells to cancer stem cells: undercurrent of cancer initiation..Cancers (Basel)2019;11: PMCID:PMC6468812

[7] Batlle E.Cancer stem cells revisited..Nat Med2017;23:1124-34

[8] Ramos EK,Gerson SL.New opportunities and challenges to defeat cancer stem cells..Trends Cancer2017;3:780-96 PMCID:PMC5958547

[9] Cohnheim J.Ueber entzündung und Eiterung..Path Anat Physiol Klin Med.1867;40:1-79

[10] Holland JD,Vogel R,Valenti G.Combined Wnt/beta-catenin, Met, and CXCL12/CXCR4 signals characterize basal breast cancer and predict disease outcome..Cell Rep2013;5:1214-27

[11] Liu S.Targeting breast cancer stem cells..J Clin Oncol2010;28:4006-12 PMCID:PMC4872314

[12] Vassiliou GS,Rad R,Rice S.Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice..Nat Genet2011;43:470-5 PMCID:PMC3084174

[13] Gudjonsson T.Stem cell biology and the cellular pathways of carcinogenesis..APMIS2005;113:922-9

[14] Al-Hajj M.Self-renewal and solid tumor stem cells..Oncogene2004;23:7274-82

[15] Chaffer CL,Scheel C,Wiggins PA.Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state..Proc Natl Acad Sci U S A2011;108:7950-5 PMCID:PMC3093533

[16] Wainwright EN.Epigenetics and cancer stem cells: unleashing, hijacking, and restricting cellular plasticity..Trends Cancer2017;3:372-86 PMCID:PMC5506260

[17] Dalerba P,Park I-K,Wang X.Phenotypic characterization of human colorectal cancer stem cells..Proc Natl Acad Sci U S A2007;104:10158-63 PMCID:PMC1891215

[18] Dean M,Bates S.Tumour stem cells and drug resistance..Nat Rev Cancer2005;5:275-84

[19] Bleau AM,Ozawa T,Huse JT.PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells..Cell Stem Cell2009;4:226-35 PMCID:PMC3688060

[20] Nieborowska-Skorska M,Dasgupta Y,Hoser G.Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells..J Clin Invest2017;127:2392-406 PMCID:PMC5451241

[21] Thiery JP.Epithelial-mesenchymal transitions in tumour progression..Nat Rev Cancer2002;2:442-54

[22] Croucher PI,Martin TJ.Bone metastasis: the importance of the neighbourhood..Nat Rev Cancer2016;16:373-86

[23] Thomas PD.Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulation..Cell Biol Toxicol2016;32:61-81

[24] Cullen SM,Rossi L.Hematopoietic stem cell development: an epigenetic journey..Curr Top Dev Biol2014;107:39-75

[25] Gage FH.Neural stem cells: generating and regenerating the brain..Neuron2013;80:588-601

[26] Clevers H.The intestinal crypt, a prototype stem cell compartment..Cell2013;154:274-84

[27] LaBarge MA.The difficulty of targeting cancer stem cell niches..Clin Cancer Res2010;16:3121-9 PMCID:PMC3182451

[28] Merchant AA.Targeting Hedgehog-a cancer stem cell pathway..Clin Cancer Res2010;16:3130-40 PMCID:PMC2888641

[29] Pannuti A,Rizzo P,Golde T.Targeting Notch to target cancer stem cells..Clin Cancer Res2010;16:3141-52 PMCID:PMC3008160

[30] Saygin C,Majeti R,Lathia JD.Targeting cancer stemness in the clinic: from hype to hope..Cell Stem Cell2019;24:25-40

[31] Crupi MJF,Singaravelu R.Concise review: targeting cancer stem cells and their supporting niche using oncolytic viruses..Stem Cells2019;37:716-23

[32] Luo M.Targeting cancer stem cell redox metabolism to enhance therapy responses..Semin Radiat Oncol2019;29:42-54

[33] Foudi A,Van Buren D,Jaenisch R.Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells..Nat Biotechnol2009;27:84-90 PMCID:PMC2805441

[34] Baker AM,Melton S,Rodriguez-Justo M.Quantification of crypt and stem cell evolution in the normal and neoplastic human colon..Cell Rep2014;8:940-7 PMCID:PMC4471679

[35] Cairns J.Mutation selection and the natural history of cancer..Nature1975;255:197-200

[36] Cicalese A,Pasi CE,Ronzoni S.The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells..Cell2009;138:1083-95

[37] Lee JY,Yilmaz OH,Joseph NM.mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion..Cell Stem Cell2010;7:593-605 PMCID:PMC2995996

[38] Ferent J,Faure H,Hahn H.Genetic activation of hedgehog signaling unbalances the rate of neural stem cell renewal by increasing symmetric divisions..Stem Cell Reports2014;3:312-23 PMCID:PMC4175546

[39] Arends CM,Hoyer K,Jager M.Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis..Leukemia2018;32:1908-19

[40] Jaiswal S,Silver AJ,Bick AG.Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease..N Engl J Med2017;377:111-21

[41] Kahn M.Can we safely target the WNT pathway?.Nat Rev Drug Discov2014;13:513-32 PMCID:PMC4426976

[42] Niehrs C.The complex world of WNT receptor signalling..Nat Rev Mol Cell Biol2012;13:767-79

[43] Moon RT.Wnt/beta-catenin pathway..Sci STKE2005;2005:cm1

[44] Lai KKY,Lee KS,Lin DP.Convergence of canonical and non-canonical Wnt signal: differential Kat3 coactivator usage..Curr Mol Pharmacol2019;[Epub ahead of print]

[45] Kim YM,Oehler VG,Nguyen C.The gamma catenin/CBP complex maintains survivin transcription in beta-catenin deficient/depleted cancer cells..Curr Cancer Drug Targets2011;11:213-25

[46] Kim K,Hay ED.Tissue-specific expression of beta-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness..Exp Cell Res1998;245:79-90

[47] Onder TT,Mani SA,Lander ES.Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways..Cancer Res2008;68:3645-54

[48] Wagh PK,Zinser GM,James L.beta-Catenin is required for Ron receptor-induced mammary tumorigenesis..Oncogene2011;30:3694-704 PMCID:PMC3134560

[49] Coluccia AM,Dekhil H,Lan C.SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling..Cancer Res2006;66:2279-86

[50] Ress A.Bcr interferes with beta-catenin-Tcf1 interaction..FEBS Lett2006;580:1227-30

[51] Ishimoto T,Oshima M,Torii R.CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis..Cancer Sci2010;101:673-8

[52] Kida A.Hypoxia selects for a quiescent, CML stem/leukemia initiating-like population dependent on CBP/catenin transcription..Curr Mol Pharmacol2013;6:204-10

[53] Mazumdar J,Johnson RS,Chavez JC.O2 regulates stem cells through Wnt/beta-catenin signalling..Nat Cell Biol2010;12:1007-13 PMCID:PMC3144143

[54] Chocarro-Calvo A,Ardila-Gonzalez S,Garcia-Jimenez C.Glucose-induced beta-catenin acetylation enhances Wnt signaling in cancer..Mol Cell2013;49:474-86

[55] Zhao CM,Kodama Y,Westphalen CB.Denervation suppresses gastric tumorigenesis..Sci Transl Med2014;6:250ra115 PMCID:PMC4374618

[56] Kawabata A.Prostaglandin E2 and pain-an update..Biol Pharm Bull2011;34:1170-3

[57] van Veelen W,Helvensteijn W,Theeuwes M.β-catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesis..Gut2011;60:1204-12 PMCID:PMC3152867

[58] Brembeck FH,Birchmeier W.Balancing cell adhesion and Wnt signaling, the key role of beta-catenin..Curr Opin Genet Dev2006;16:51-9

[59] Komiya Y.Wnt signal transduction pathways..Organogenesis2008;4:68-75 PMCID:PMC2634250

[60] Sato N,Skaltsounis L,Brivanlou AH.Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor..Nat Med2004;10:55-63

[61] Otero JJ,Kan L,Kessler JA.Beta-catenin signaling is required for neural differentiation of embryonic stem cells..Development2004;131:3545-57

[62] Kahn M.Symmetric division versus asymmetric division: a tale of two coactivators..Future Med Chem2011;3:1745-63

[63] Kuhl SJ.On the role of Wnt/beta-catenin signaling in stem cells..Biochim Biophys Acta2013;1830:2297-306

[64] Anastas JN.WNT signalling pathways as therapeutic targets in cancer..Nat Rev Cancer2013;13:11-26

[65] Polakis P.Wnt signaling in cancer..Cold Spring Harb Perspect Biol2012;4: PMCID:PMC3331705

[66] Blum B,Golan-Lev T.The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells..Nat Biotechnol2009;27:281-7

[67] Hoffmeyer K,Rudloff S,Hierholzer A.Wnt/beta-catenin signaling regulates telomerase in stem cells and cancer cells..Science2012;336:1549-54

[68] DiMeo TA,Phadke P,Perou CM.A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer..Cancer Res2009;69:5364-73 PMCID:PMC2782448

[69] Mani SA,Liao MJ,Ayyanan A.The epithelial-mesenchymal transition generates cells with properties of stem cells..Cell2008;133:704-15 PMCID:PMC2728032

[70] Sack U,Scudiero D,Aumann J.S100A4-induced cell motility and metastasis is restricted by the Wnt/beta-catenin pathway inhibitor calcimycin in colon cancer cells..Mol Biol Cell2011;22:3344-54 PMCID:PMC3172260

[71] Yu M,Stott SL,Ozsolak F.RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis..Nature2012;487:510-3 PMCID:PMC3408856

[72] Zhuang X,Li X,Cong M.Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1..Nat Cell Biol2017;19:1274-85

[73] Peinado H,Matei IR,Hoshino A.Pre-metastatic niches: organ-specific homes for metastases..Nat Rev Cancer2017;17:302-17

[74] Lickert H,Huls G,Duluc I.Wnt/(beta)-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine..Development2000;127:3805-13

[75] Russell RG,Dettin LE.Id2 drives differentiation and suppresses tumor formation in the intestinal epithelium..Cancer Res2004;64:7220-5

[76] Barker N,Kuipers J,van den Born M.Identification of stem cells in small intestine and colon by marker gene Lgr5..Nature2007;449:1003-7

[77] Wielenga VJ,Korinek V,Kielman M.Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway..Am J Pathol1999;154:515-23 PMCID:PMC1850011

[78] Shulewitz M,Wu T,Polakis P.Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer..Oncogene2006;25:4361-9

[79] Katoh Y.Comparative genomics on PROM1 gene encoding stem cell marker CD133..Int J Mol Med2007;19:967-70

[80] Correa S,Du Rocher B,Pizzatti L.Wnt/beta-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia..BMC Cancer2012;12:303 PMCID:PMC3464798

[81] Yamada T,Naishiro Y,Maruyama K.Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis..Cancer Res2000;60:4761-6

[82] Yamashita T,Forgues M.Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma..Cancer Res2007;67:10831-9

[83] Al-Hajj M,Benito-Hernandez A,Clarke MF.Prospective identification of tumorigenic breast cancer cells..Proc Natl Acad Sci U S A2003;100:3983-8 PMCID:PMC153034

[84] Wang Y,Sinha AU,Goessling W.The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML..Science2010;327:1650-3 PMCID:PMC3084586

[85] Radich JP,Mao M,Schelter J.Gene expression changes associated with progression and response in chronic myeloid leukemia..Proc Natl Acad Sci U S A2006;103:2794-9 PMCID:PMC1413797

[86] Pehlivan M,Sercan HO.sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia..Leuk Res2009;33:1062-7

[87] Zhao Y,Yi J,Chen L.The role of canonical Wnt signaling in regulating radioresistance..Cell Physiol Biochem2018;48:419-32

[88] Katoh M.Canonical and non-canonical WNT signaling in cancer stem cells and their niches: cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)..Int J Oncol2017;51:1357-69 PMCID:PMC5642388

[89] Spranger S.Impact of oncogenic pathways on evasion of antitumour immune responses..Nat Rev Cancer2018;18:139-47

[90] Schinzari V,Pecora G,Gallerano D.Wnt3a/beta-catenin signaling conditions differentiation of partially exhausted T-effector cells in human cancers..Cancer Immunol Res2018;6:941-52

[91] Suryawanshi A.Tumors induce immune tolerance through activation of beta-catenin/TCF4 signaling in dendritic cells: A novel therapeutic target for cancer immunotherapy..Oncoimmunology2015;4:e1052932 PMCID:PMC4635893

[92] Wang B,Kalland KH,Qu Y.Targeting Wnt/beta-catenin signaling for cancer immunotherapy..Trends Pharmacol Sci2018;39:648-58

[93] Takahashi-Yanaga F.Targeting Wnt signaling: can we safely eradicate cancer stem cells?.Clin Cancer Res2010;16:3153-62

[94] Acebron SP.beta-catenin-independent roles of Wnt/LRP6 signaling..Trends Cell Biol2016;26:956-67

[95] Veeman MT,Moon RT.A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling..Dev Cell2003;5:367-77

[96] Nowak D,Koeffler HP.Differentiation therapy of leukemia: 3 decades of development..Blood2009;113:3655-65 PMCID:PMC2943835

[97] Teo JL.The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators..Adv Drug Deliv Rev2010;62:1149-55

[98] Ma H,Lee KS.Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression..Oncogene2005;24:3619-31

[99] Roth JF,Henzen C,Lutz W.Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5..EMBO J2003;22:5186-96 PMCID:PMC204457

[100] Yamauchi T,Kamon J,Komeda K.Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice..Nat Genet2002;30:221-6

[101] Kung AL,Bronson RT,Sieff CA.Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP..Genes Dev2000;14:272-7 PMCID:PMC316359

[102] Emami KH,Ma H,Jeong KW.A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]..Proc Natl Acad Sci U S A2004;101:12682-7 PMCID:PMC515116

[103] McMillan M.Investigating Wnt signaling: a chemogenomic safari..Drug Discov Today2005;10:1467-74

[104] Manegold P,Wu Y,Lenz HJ.Differentiation therapy targeting the beta-catenin/CBP interaction in pancreatic cancer..Cancers (Basel)2018;10: PMCID:PMC5923350

[105] Zhao Y,McMillian M,Wu Y.CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells..Oncogene2016;35:3705-17 PMCID:PMC5526055

[106] Banerjee ER,Papayannopoulou T,Murry CE.Human embryonic stem cells differentiated to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model..PLoS One2012;7:e33165 PMCID:PMC3314647

[107] Hasegawa K,Teo JL,McMillan M.Wnt signaling orchestration with a small molecule DYRK inhibitor provides long-term xeno-free human pluripotent cell expansion..Stem Cells Transl Med2012;1:18-28 PMCID:PMC3727690

[108] Teo JL,Nguyen C,Kahn M.Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation..Proc Natl Acad Sci U S A2005;102:12171-6 PMCID:PMC1189325

[109] Miyabayashi T,Yamamoto M,Nguyen C.Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency..Proc Natl Acad Sci U S A2007;104:5668-73 PMCID:PMC1838514

[110] Zhao Y,Nguyen C,Melendez E.Small molecule p300/catenin antagonist enhances hematopoietic recovery after radiation..PLoS One2017;12:e0177245 PMCID:PMC5423697

[111] Higuchi Y,Yasuda SY,Hasegawa K.Specific direct small molecule p300/beta-catenin antagonists maintain stem cell potency..Curr Mol Pharmacol2016;9:272-9

[112] Marson A,Chevalier B,Kahn M.Wnt signaling promotes reprogramming of somatic cells to pluripotency..Cell Stem Cell2008;3:132-5 PMCID:PMC3235673

[113] Ring A,Smbatyan G,Yu M.CBP/beta-catenin/FOXM1 is a novel therapeutic target in triple negative breast cancer..Cancers (Basel)2018;10: PMCID:PMC6315782

[114] Gang EJ,Pham J,Nguyen C.Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia..Oncogene2014;33:2169-78 PMCID:PMC3994178

[115] Wend P,Zhu Q,Loddenkemper C.Wnt/beta-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours..EMBO J2013;32:1977-89 PMCID:PMC3715856

[116] Hao S,Li Y,Hou Y.Targeted inhibition of beta-catenin/CBP signaling ameliorates renal interstitial fibrosis..J Am Soc Nephrol2011;22:1642-53 PMCID:PMC3171936

[117] Henderson WR, Jr.,Ye X,Tien YT.Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis..Proc Natl Acad Sci U S A2010;107:14309-14 PMCID:PMC2922550

[118] Sasaki T,Nguyen C,Kahn M.The small molecule Wnt signaling modulator ICG-001 improves contractile function in chronically infarcted rat myocardium..PLoS One2013;8:e75010 PMCID:PMC3771968

[119] Ring A,Kahn M.Wnt/catenin signaling in adult stem cell physiology and disease..Stem Cell Rev2014;10:512-25 PMCID:PMC4294579

[120] El-Khoueiry AB,Yang D,Kahn M.A phase I first-in-human study of PRI-724 in patients (pts) with advanced solid tumors..J Clin Oncol2013;31:2501

[121] Kimura K,Shibakawa M,Harada K.Safety, tolerability, and preliminary efficacy of the anti-fibrotic small molecule PRI-724, a CBP/β-catenin inhibitor, in patients with hepatitis C virus-related cirrhosis: a single-center, open-label, dose escalation phase 1 trial..EBioMedicine2017;23:79-87 PMCID:PMC5605374

[122] Bakker ST.Resilient and resourceful: genome maintenance strategies in hematopoietic stem cells..Exp Hematol2013;41:915-23 PMCID:PMC3833969

[123] Orford KW.Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation..Nat Rev Genet2008;9:115-28

[124] Kohli L.Surviving change: the metabolic journey of hematopoietic stem cells..Trends Cell Biol2014;24:479-87 PMCID:PMC4112160

[125] Panopoulos AD.Anaerobicizing into pluripotency..Cell Metab2011;14:143-4

[126] Trosko JE.Evolution of energy metabolism, stem cells and cancer stem cells: how the warburg and barker hypotheses might be linked..Int J Stem Cells2012;5:39-56 PMCID:PMC3840988

[127] Mi H,Thomas PD.PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees..Nucleic Acids Res2013;41:D377-86 PMCID:PMC3531194

[128] Arany Z,Livingston DM.E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators..Cell1994;77:799-800

[129] Eckner R,Ewen M,Livingston DM.The adenovirus E1A-associated 300-kD protein exhibits properties of a transcriptional coactivator and belongs to an evolutionarily conserved family..Cold Spring Harb Symp Quant Biol1994;59:85-95

[130] Ono M,Wu K,Lin DP.Nuclear receptor/Wnt beta-catenin interactions are regulated via differential CBP/p300 coactivator usage..PLoS One2018;13:e0200714 PMCID:PMC6051640

[131] Kamei Y,Heinzel T,Kurokawa R.A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors..Cell1996;85:403-14

[132] Holstein TW.The evolution of the Wnt pathway..Cold Spring Harb Perspect Biol2012;4:a007922 PMCID:PMC3385961

[133] Markov GV.Origin and evolution of the ligand-binding ability of nuclear receptors..Mol Cell Endocrinol2011;334:21-30

[134] Jackson SP.The DNA-damage response in human biology and disease..Nature2009;461:1071-8 PMCID:PMC2906700

[135] Brown SA.Circadian clock-mediated control of stem cell division and differentiation: beyond night and day..Development2014;141:3105-11

[136] Davis S,Stevens RG.Night shift work, light at night, and risk of breast cancer..J Natl Cancer Inst2001;93:1557-62

[137] Schernhammer ES,Speizer FE,Hunter DJ.Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study..J Natl Cancer Inst2001;93:1563-8

[138] Chen Z.A conserved DNA damage response pathway responsible for coupling the cell division cycle to the circadian and metabolic cycles..Cell Cycle2007;6:2906-12

[139] Dierickx P,Geijsen N.Circadian clocks: from stem cells to tissue homeostasis and regeneration..EMBO Rep2018;19:18-28 PMCID:PMC5757216

[140] Bass J.Circadian integration of metabolism and energetics..Science2010;330:1349-54 PMCID:PMC3756146

[141] Etchegaray JP,Wade PA.Rhythmic histone acetylation underlies transcription in the mammalian circadian clock..Nature2003;421:177-82

[142] Dillard AC.Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines..Mol Carcinog2007;46:315-29

[143] Szeto W,Tice DA,Hollingshead PG.Overexpression of the retinoic acid-responsive gene <strong><em>Stra6</em></strong> in human cancers and its synergistic induction by Wnt-1 and retinoic acid..Cancer Res2001;61:4197-205

[144] Mullen EM,Cooney AJ.Nuclear receptors in regulation of mouse ES cell pluripotency and differentiation..PPAR Res2007;2007:61563 PMCID:PMC2233893

[145] Sasaki T.Inhibition of beta-catenin/p300 interaction proximalizes mouse embryonic lung epithelium..Transl Respir Med2014;2:8 PMCID:PMC4229507

[146] Suzuki S,Tsukamoto S,Imai H.ING3 is essential for asymmetric cell division during mouse oocyte maturation..PLoS One2013;8:e74749 PMCID:PMC3774679

[147] Huynh JR.The origin of asymmetry: early polarisation of the Drosophila germline cyst and oocyte..Curr Biol2004;14:R438-49

[148] Kim YM,Kahn M.CBP/catenin antagonists: targeting LSCs’ achilles heel..Exp Hematol2017;52:1-11 PMCID:PMC5526056